HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property. - Wikidata - awgldk - TriplyDB

HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property.

HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property.

http://www.wikidata.org/entity/Q37326921

about

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.Phosphorylation of AKT and abdominal aortic aneurysm formation.Calreticulin: non-endoplasmic reticulum functions in physiology and disease.Protein targets of inflammatory serine proteases and cardiovascular disease.Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency.High density lipoprotein: it's not just about lipid transport anymore Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans.Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions.Effect of dietary fatty acids on serum parameters, fatty acid compositions, and liver histology in Shaoxing laying ducks Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells High Density Lipoprotein and it's Dysfunction Novel biological functions of high-density lipoprotein cholesterol Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties High-density lipoproteins limit neutrophil-induced damage to the blood-brain barrier in vitro.Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model.HDL and endothelial protection.Refined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity.Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm.HDL and cholesterol: life after the divorce?Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency Intraplaque haemorrhages as the trigger of plaque vulnerability.HDL-mediated mechanisms of protection in cardiovascular disease.High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.Kidney remote ischemic preconditioning as a novel strategy to explore the accurate protective mechanisms underlying remote ischemic preconditioning.Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse model

P2860

Q28075541-C3D69BE6-C621-41A5-9C39-C3933FD8C67C Q28387051-413525B7-D56D-4D4E-8519-BC0BBF634186 Q30408731-B030C6E4-6903-4335-B679-7A3BF5018800 Q33694634-8B7FE635-52C2-4481-A0F9-863CDDFD5096 Q34114355-AB516D4A-B04E-4923-A6F5-38DB9BABE572 Q34390616-88DA6BEB-4637-446A-8F87-F8C89268DF58 Q34419196-54ECD4CF-9D0A-41C8-9329-845FB35A2EEA Q34565254-38B15F18-A502-49A7-82D8-1FF39F038350 Q34682737-6B497D59-5C58-4598-8966-24A29119ADF2 Q35149530-B5AA9049-62A2-4A75-99C7-1C5B5D78FBF6 Q35199168-35DC36ED-447E-49BA-929B-353107875D68 Q35959814-DB903610-1E9C-47DE-8E07-2CB24C1EAC40 Q36150462-D882A04C-0537-4784-890B-E0A9B8040BFA Q36406480-62CDAFD6-17E3-45BB-80DA-4E32E87E0616 Q36604395-95855064-3CCC-41D3-9B55-2800A498541D Q36745104-E75DD592-88BA-4AE3-8229-F7CECAA0FE52 Q36826903-26DEB221-9A7A-494E-B191-00C8802A09B1 Q36929420-2737FC9C-A326-438F-ACF3-94F360A8544B Q37472192-71A0A52F-4DF0-427F-9B8D-A7D6455B9F22 Q37488099-90B5B58F-1BED-48AD-B5A6-14C531C9471F Q37590250-13DE8BDC-FD5B-409B-A8CA-F69AC2494F9F Q37725572-8374ECB7-7079-4D76-B9B8-8D5D0A21E339 Q37852494-AC5051A1-FD9E-4F7B-90B1-71680E076390 Q38220762-09777E9B-559B-4032-B4B6-855C90DD033B Q38436472-0F214BE5-D677-4A43-8DB4-B5D057354F5B Q41105255-79BDF95F-6D91-4D8B-B068-EBA97D1F439D Q46269480-A94F900C-325F-4039-B476-CB154C4EAA67 Q47747847-E913AFC7-AFCB-4FDA-9264-E539948513AA Q51465416-6974504E-FF80-4405-A719-3A6C49C2FA20 Q58798270-6898E51A-8590-410A-88D1-1CA279A3AE96

P2860

HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property.

http://www.wikidata.org/entity/Q37326921

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HDL antielastase activity prev ...... new antiatherogenic property.

@en

HDL antielastase activity prev ...... new antiatherogenic property.

@nl

type

label

HDL antielastase activity prev ...... new antiatherogenic property.

@en

HDL antielastase activity prev ...... new antiatherogenic property.

@nl

prefLabel

HDL antielastase activity prev ...... new antiatherogenic property.

@en

HDL antielastase activity prev ...... new antiatherogenic property.

@nl

P1433

Q37326921-C46C39DA-2D84-493A-81FE-F41687AC2F84

P1476

Q37326921-F8C3CCE5-229D-4502-BB22-E19D3E18BAC0

P2093

Q37326921-0975D0C2-D848-41F6-B146-C31954E9A502

Q37326921-31A99681-58E0-4D0A-9980-355F587E6EB6

Q37326921-560B6545-3955-4EBC-AA67-C45CE1CC2693

Q37326921-5D068645-9092-4E67-A029-BD4E216C4415

Q37326921-60D59D88-219F-4B88-A140-6ADC441A3D15

Q37326921-82AD17B8-6CF8-4C15-8B00-7D0A1149EC97

Q37326921-93F4EC18-FDA1-4BCB-9CF2-18CF2F65ED54

Q37326921-AF6CF488-7A0C-4507-91E7-3244C6993465

Q37326921-B4CB1447-7079-46A8-BAEF-7EC61FABE734

Q37326921-D018131D-F476-4A12-A446-B623A4CD2381

P2860

Q37326921-13D561D7-645E-49AF-A846-1AFB06D2DB56

Q37326921-18F0C898-DB81-4A4B-ABC3-F72ACE3701C3

Q37326921-1AF81695-368E-4D2B-8EB4-2B1FD49106A1

Q37326921-2494F743-51EA-4914-A196-80523DB9A562

Q37326921-2D627499-EF1B-4809-8D34-E90741C29F4C

Q37326921-3C3817BD-9A76-4B99-9524-A8632C39F7BB

Q37326921-4FF521C6-E9D5-434F-9688-8B78D136A344

Q37326921-51B2D67B-17AE-4434-8E5E-0CB74BD01EE1

Q37326921-54CBD55C-9465-4B29-95B3-C21F4C32DD99

Q37326921-5F391043-6051-46B9-869E-E7C6F03D9867

P304

Q37326921-6FA6A2EC-CEAA-4591-81A1-78DFC4D0785B

P31

Q37326921-8092D0A9-E307-407C-9C6B-AF854D84C7C3

P356

Q37326921-F2F07AB8-0524-4B0F-B40A-5C33B8F16EAF

P407

Q37326921-8D3FA607-B48E-4E77-B6AA-88FE2BAC5B1D

P433

Q37326921-561746C3-3E4C-46F6-9E32-BD9024D5FD82

P478

Q37326921-EC798E01-D32A-40DE-A18F-5D2B291B5809

P50

Q37326921-7779F2AB-C552-4E62-983A-8BE5C41CB2DC

P577

Q37326921-742A10C0-1893-4DF2-AE5E-BDD65275A917

P5875

Q37326921-CDDCC66F-4F99-4B6D-96FA-298D9995DB64

P698

Q37326921-FE7E2EFA-6B5A-470D-A98E-130367BE274C

P932

Q37326921-5AAEA0B2-43EA-4E63-A827-C4DC6250827B

P356

P1433

P1476

HDL antielastase activity prev ...... new antiatherogenic property.

@en

P2093

Alma L Burlingame

http://www.w3.org/2001/XMLSchema#string

Brian Y Ishida

http://www.w3.org/2001/XMLSchema#string

Guadalupe Ortiz-Muñoz

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Michel

http://www.w3.org/2001/XMLSchema#string

John P Kane

http://www.w3.org/2001/XMLSchema#string

Jose-Luis Martín-Ventura

http://www.w3.org/2001/XMLSchema#string

Juan-Antonio Moreno

http://www.w3.org/2001/XMLSchema#string

Olivier Meilhac

http://www.w3.org/2001/XMLSchema#string

Robert J Chalkley

http://www.w3.org/2001/XMLSchema#string

Stéphane Loyau

http://www.w3.org/2001/XMLSchema#string

P2860

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.

Optimization of in-gel protein digestion system in combination with thin-gel separation and negative staining in 96-well plate format.

Identification of apoptotic cells by formamide-induced dna denaturation in condensed chromatin.

Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.

Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.

Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus.

High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

Anoikis in the cardiovascular system: known and unknown extracellular mediators.

P304

3129-3139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.08-127928

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Rossignol

P577

2009-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24403299

http://www.w3.org/2001/XMLSchema#string

P698

19417089

http://www.w3.org/2001/XMLSchema#string

P932

2735359

http://www.w3.org/2001/XMLSchema#string